 SALT LAKE CITY, Oct. 6, 2021 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd CoSara, or the JV, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization CDSCO in India to manufacture and sell its SarageneTM Dengue and Chikungunya Multiplex RT-PCR test as an in vitro diagnostic IVD. The CDSCO approval marks the 10th assay manufactured and sold by CoSara to receive clearance from the CDSCO, and follows the recent clearance of standalone dengue and chikungunya assays last month. 